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Abstract  
In neurodegenerative disorders, apathy is often linked to more rapid disease progression and 
subsequent cognitive decline, whereas results for such a relationship between depression and 
cognition remain inconsistent. One of the risk factors for neurodegenerative disorders and 
overall cognitive dysfunction is midlife hypertension, however there is limited understanding 
of the factors affecting cognition in elderly hypertension patients. We aimed to explore the 
predictive effects of apathy and depression on cognitive decline after four years of follow up 
in a population of elderly hypertension patients. Baseline data of 308 participants were 
retrieved from the Discontinuation of Antihypertensive Treatment in Elderly People on 
Cognitive Functioning (DANTE) study, with 154 participants providing complete follow up 
data for the analyses in the current longitudinal study. Apathy and depression were measured 
with self-report questionnaires at baseline. Six cognitive tests were administered at baseline 
and follow up as an indicator of cognitive decline, measuring executive dysfunction, 
memory, and psychomotor speed. Three linear regression analyses were performed to study 
the relationship between apathy, depression, and their shared predictive effect (independent 
variables), and cognitive decline (dependent variable). Results indicate that average scores 
declined over time on nearly all cognitive tests. However, cognitive decline was not 
significantly related to apathy (p = 0.366) nor depression (p = 0.283). There was no 
interaction effect of apathy and depression (p = 0.442). Thus, apathy and depression were not 
found to be longitudinally associated with cognitive decline in this study sample. However, 
attrition was substantial due to the systematic dropout of the subjects with the worst cognitive 
performance, introducing bias. Based on the results of the current study it cannot be said that 
apathy, depression, or the interaction between these two constructs have a significant 
predictive effect on cognitive decline in elderly hypertension patients.  
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Layman’s Abstract  
Depression and apathy are two factors playing a possible role in intellectual 
functioning. Studies often find apathy, described as a lack of interest or enthusiasm, to be 
related to worse intellectual functioning in dementia patients. On the other hand, the effects 
of depression on intellectual functioning remain unclear. Also, high blood pressure during 
midlife is considered a risk factor for worse intellectual functioning later in life, whilst we 
know little about the effects of high blood pressure in the elderly on their intellectual 
functioning. Knowing more about the factors at play when it comes to intellectual functioning 
in these elderly people may help us prevent or delay the onset of dementia.  
As such, the current study aims to assess whether apathy and depression in elderly 
people with high blood pressure can predict a decline in intellectual functioning. The current 
study measured apathy, depression, and intellectual functioning of 154 healthy people at the 
beginning of the study. Measurements for intellectual functioning were repeated four years 
later. As such, we could analyze if the difference in intellectual functioning between the start 
of the study and four years later was due to apathy and depression.  
Results indicate that people performed less well on the intellectual tests four years 
later than at the start of the study. But, this decline was not related to levels of apathy or 
depression at the start of the study. In conclusion, apathy and depression at the start of the 
study could not predict the decline in intellectual functioning at the end of the study, at least 
not in these elderly people with high blood pressure. However, many people who completed 
the measurements at the start of the study were not able to return for the measurements at the 
end of the study. This is true especially for those whom performed the worst intellectually. 
As such, our results may be distorted due to the loss of our intellectually poorest participants. 
Still, based on our results, apathy or depression cannot predict a decline in intellectual 
functioning in elderly people with high blood pressure.  
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Introduction 
Apathy and depression are the most common neuropsychiatric symptoms experienced 
by patients suffering from mild or severe cognitive impairment, with detrimental effects on the 
well-being of patients and their caregivers (Cortes, Andrade, & Maccioni, 2018; Palmer et al., 
2010; Vloeberghs, Opmeer, Deyn, Engelborghs, & Deroeck, 2018). Although apathy and 
depression often occur together and are thus difficult to differentiate in clinical practice, studies 
indicate that they are separate constructs and should be recognized as distinct clinical entities 
(Hollocks et al., 2015; Kirsch-Darrow, Marsiske, Okun, Bauer, & Bowers, 2011; Richard et 
al., 2012; Vloeberghs et al., 2018). Apathy is defined as “a loss of, or diminished motivation, 
in combination with reduction in either goal-directed behavior, cognitive activity or emotional 
expression” (Hollocks et al., 2015, p. 3804). Apathetic patients often appear indifferent and 
display a lack of motivation and productivity, a loss of initiative and interest, and blunted 
emotions (Kirsch-Darrow et al., 2011; Vloeberghs et al., 2018). Reduced motivation and loss 
of interest are also important characteristics of depression, but unlike apathy, depression is 
additionally “characterized by feelings of sadness, low mood, appetite disturbance, suicidal 
ideation, and helplessness” (Fishman et al., 2018, p. 450). Depressed patients are extremely 
self-critical, are unable to anticipate happiness or pleasure, experience feelings of 
worthlessness, and are known to ruminate extensively (Parker, McCraw, & Paterson, 2015).   
Previous research has shown that apathy and depression are differentially related to 
various neurological conditions. Apathy is highly prevalent in severe dementia and has often 
been studied in patients with Alzheimer’s disease (AD), Parkinson’s disease (PD), and mild 
cognitive impairment (MCI) (Fitts et al., 2015; Kirsch-Darrow et al., 2011; Palmer et al., 
2010; Starkstein, Jorge, Mizrahi, & Robinson, 2006). Apathy increases the risk of 
progression from MCI to AD, and seems to predict the development of dementia in PD (Fitts 
et al., 2015; Kirsch-Darrow et al., 2011; Palmer et al., 2010; Richard et al., 2012). 
Furthermore, research conducted with 354 outpatients in a dementia clinic indicated that 
apathetic AD patients display a greater cognitive and functional decline compared to AD 
patients who are not apathetic (Starkstein et al., 2006). Follow up was conducted with 70% of 
the participants, between 1 and 4 years after evaluation. According to Starkstein et al. (2006), 
loss at follow up was mainly due to death or severe dementia, also stating that those who 
were not evaluated at follow up were older and suffered from higher levels of apathy than 
those who did reach follow up.  
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Although depression is common in dementia patients as well, it is unclear whether 
depression is associated with disease progression and subsequent cognitive decline (Richard 
et al., 2012; Vloeberghs et al., 2018). For instance, Richard et al. (2012) found no association 
between a depressive mood and an increased risk of progression from MCI to dementia, 
whilst they did find such an association for apathy. Likewise, amnestic MCI patients with 
depression had no increased risk for developing AD, whilst amnestic MCI patients with 
apathy were shown to have a sevenfold increased risk of developing AD (Palmer et al., 
2010). However, Steenland et al. (2012) did find a recent, but not remitted, depression in late-
life to be a strong risk factor for developing MCI and to a lesser extent for progressing from 
MCI to AD. 
Apathy and depression are also prevalent in other cerebrovascular diseases, such as 
cerebral small vessel disease (CSVD). The high incidence of apathy and depression in CSVD 
may be due to white matter damage to the cortico-subcortical pathways important for 
emotion regulation, reward, and goal-directed behavior (Hollocks et al., 2015). CSVD 
incidence increases with age and is a major cause of cognitive dysfunction, characterized by 
white matter lesions, lacunar infarcts, cerebral microbleeds and brain atrophy (Hollocks et al., 
2015; Moonen et al., 2017). High blood pressure, known as hypertension, has been 
demonstrated to be a strong risk factor during midlife for CSVD and general cognitive 
dysfunction later in life (Foster-Dingley et al., 2015). On the contrary, the relationship 
between cognition and hypertension in older persons rather than in middle-aged persons is 
less clear (Foster-Dingley et al., 2015; Moonen, Foster-Dingley, et al., 2015; Walker, Power, 
& Gottesman, 2017). Therefore, the Discontinuation of Antihypertensive Treatment in 
Elderly People on Cognitive Functioning (DANTE) study was set up in Leiden to examine 
the relationship between blood pressure and cognition in older persons (see Design section 
below) (Moonen, Foster-Dingley, et al., 2015). Considering the high prevalence of 
hypertension and its well-known role as modifiable risk factor of cerebrovascular disease, 
understanding the factors contributing to cognitive dysfunction in elderly hypertension 
patients could provide relevant information for preventing or delaying age-related cognitive 
disorders (Walker et al., 2017).  
Cognitive disorders have become a recurrent topic in research, especially in light of the 
rapid aging of the global population. In the year 2050, 22% of the global population is estimated 
to be aged 60 years or older, compared to just 11% in 2011 (Bloom, 2011). This aging trend 
implies that the incidence of age-related disorders such as MCI and dementia will increase as 
well (Vloeberghs et al., 2018). With an estimated 47 million people currently suffering from 
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dementia globally, a number which is expected to have nearly doubled by 2040, the prevention 
of dementia is considered a major public health crisis and substantial financial investment 
(Chibnik et al., 2017; James & Bennett, 2019). Insight in the effects of apathy and depression 
on subsequent cognitive decline could contribute to a better understanding of indications or 
risk factors for serious cognitive disorders, and possibly prevent or delay the onset of dementia 
(Walker et al., 2017).  
To summarize the results of previous studies, research seems to support the role of 
apathy as a predictor of cognitive decline in patients suffering from AD, PD, and MCI, as well 
as being a common symptom of CSVD (Fitts et al., 2015; Hollocks et al., 2015; Kirsch-Darrow 
et al., 2011; Palmer et al., 2010; Richard et al., 2012). However, the predictive value of apathy 
on cognitive decline in a population of elderly hypertension patients has, to the best of our 
knowledge, not been investigated yet. Moreover, although most studies do find heightened 
levels of depression in cerebrovascular diseases such as AD, PD, MCI, and CSVD, results 
remain inconclusive concerning its predictive value for cognitive decline (Richard et al., 2012; 
Steenland et al., 2012; Vloeberghs et al., 2018). Therefore, the aim of the current master thesis 
study is to explore the predictive effect of apathy and depression, respectively and interactively, 
on cognitive decline after four years of follow up in a sample of older hypertension patients.  
Based on the aforementioned research, it is firstly hypothesized that apathy has a 
predictive effect on cognitive decline in older subjects with a history of hypertension. 
Considering indications that apathy plays a role in disease progression in AD, PD, MCI, and 
CSVD (Fitts et al., 2015; Hollocks et al., 2015; Kirsch-Darrow et al., 2011; Palmer et al., 
2010; Richard et al., 2012), and the known associations between CSVD, cognitive decline, 
and hypertension (Foster-Dingley et al., 2015; Walker et al., 2017), it seems likely that higher 
levels of apathy may be related to more cognitive decline in hypertension patients as well.  
Secondly, it is hypothesized that depression does not have a predictive effect on 
cognitive decline in this sample of older hypertension patients. Depression seems to be a 
common symptom experienced by those suffering from AD, PD, MCI, and CSVD, but results 
concerning a predictive effect of depression on cognitive decline in such cerebrovascular 
diseases are inconsistent (Richard et al., 2012; Steenland et al., 2012; Vloeberghs et al., 
2018). Thus, higher levels of depression are not expected to be related to more cognitive 
decline in elderly hypertension patients.  
Finally, it is hypothesized that the interactive effect between apathy and depression 
cannot be considered a predictor of cognitive decline in older hypertension patients. Research 
supports the notion that apathy and depression are distinct clinical entities, as studies have 
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shown that they do not always occur together, have unique characteristics, and seem to rely on 
different neural networks (Hollocks et al., 2015; Kirsch-Darrow et al., 2011; Richard et al., 
2012; Vloeberghs et al., 2018). Furthermore, previous research finds mixed results concerning 
the interactive effect of apathy and depression on cognition. Several studies find no interaction 
at all, or no added effect of depression, whilst others find an interaction only on some cognitive 
subtests (Baudic et al., 2006; Meyer et al., 2014; Nakaaki et al., 2008; Zhu, Grossman, & Sano, 
2019). As such, the predictive effects of apathy and depression are not expected to strengthen 
or weaken each other. Thus, the interaction between apathy and depression is not expected to 
be related to more cognitive decline in elderly hypertension patients.  
 
Methods 
Design  
Data used in this current study were retrieved from the DANTE study Leiden, a 
longitudinal, community-based, randomized nonblinded clinical trial (Foster-Dingley et al., 
2015; Moonen, Foster-Dingley, et al., 2015). This study was designed to assess whether 
discontinuation of antihypertensive treatment in older persons with mild cognitive deficits 
improves cognitive, psychological, and general daily functioning. Measurements were 
performed at baseline (June 2011 through August 2013) and repeated after sixteen weeks and 
after four years. A more detailed description of DANTE is given elsewhere (Moonen, Foster-
Dingley, et al., 2015). The current master thesis study has a longitudinal design, exploring 
apathy and depression measured at baseline (independent variables) as predictors of cognitive 
decline at the four year follow up (dependent variable) in the DANTE sample.  
 
Participants 
Participants for the DANTE study were recruited from 128 general practices in the 
Netherlands. Participants were included if they “were 75 years or older, used antihypertensive 
treatment, had a systolic BP (SBP) of 160 mm Hg or less, and had a Mini-Mental State 
Examination (MMSE) score of 21 to 27” (Moonen, Foster-Dingley et al., 2015, p. 1623). The 
current master thesis study maintains the same in- and exclusion criteria as the DANTE 
study, which are described in further detail in the article by Moonen and Foster-Dingley et al. 
(2015). Moreover, two additional inclusion criteria were maintained in the current master 
thesis study. Firstly, participants were included in the analyses if the Apathy Scale (AS) and 
the Geriatric Depression Scale-12 (GDS-12) had been administered at baseline (see Measures 
section for description of tests). Secondly, participants for whom at least five out of the six 
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cognitive tests were available at baseline or follow up were included in the analyses (see 
Measures section). Maintaining these additional inclusion criteria resulted in an included 
group (n = 154) and an excluded group (n = 154) of subjects used in the analyses for the 
current master thesis study (see Figure A1). Baseline measurements of 308 participants were 
used for the current study. Baseline characteristics are described in the Results section. 
As previously described, the DANTE study is a randomized clinical trial designed to 
examine the effects of discontinuing antihypertensive treatment (Moonen, Foster-Dingley et 
al., 2015). Therefore, subjects were randomized to either the intervention group or the control 
group. However, group allocation is not relevant for the current master thesis study, as this 
study is focused on all hypertension patients irrespective of the use of antihypertensive 
treatment. Thus, the groups used for the DANTE study will not be taken into account (for 
further details see Moonen, Foster-Dingley et al., 2015).  
 
Measures  
Apathy was measured using the Apathy Scale (AS) (Starkstein et al., 1992). The AS 
consists of 14 items with four answer categories. Scores range from 0 to 42 points, with 
higher scores indicating more symptoms of apathy. The intra- and interrater reliability of the 
AS has been rated as very high (Starkstein et al., 1992).  
Depression was measured with the Geriatric Depression Scale-12 (GDS-12) (van der 
Mast et al., 2008; Van Wanrooij, Borsboom, Moll van Charante, Richard, & Van Gool, 
2019). The GDS-12 is a shortened version of the Geriatric Depression Scale-15 (GDS-15), 
after factor analysis showed three items (namely item 2, 9, and 13) of the GDS-15 loaded on 
apathy rather than depression (van der Mast et al., 2008; Van Wanrooij et al., 2019). The 
GDS-12 is a self-report screening scale for depression consisting of 12 items which can be 
answered with “yes” or “no”. Scores range from 0 to 12 points, with higher scores indicating 
more symptoms of depression (van der Mast et al., 2008).  
To measure cognitive decline, the change (∆) in overall cognition compound score 
between baseline and four year follow up was used. The overall cognition compound score 
was determined both at baseline and follow up by first calculating the standardized Z-scores 
of the six cognitive tests administered at baseline and repeated at follow up. Then, the mean 
of these six standardized test scores was used as the overall cognition compound score. 
Lastly, the change (∆) was calculated by subtracting the overall cognition compound score at 
baseline from the overall cognition compound score at follow up. Thus, delta scores of zero 
or higher indicated no cognitive decline or an increase in performance over time, whereas 
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delta scores below zero indicated cognitive decline, defined as a decrease in performance 
over time.  
The six cognitive tests that were administered to calculate the overall cognition 
compound scores loaded on three different cognitive domains (Moonen, Foster-Dingley, et 
al., 2015). First, the difference (Δ) between the time needed to complete the Trail Making 
Tests parts A (TMT-A) and B (TMT-B) as well as the time needed to complete the 
interference trial of the abbreviated Stroop Color-Word Test measured executive functioning 
(Moonen, Foster-Dingley, et al., 2015). In the TMT-A subjects are asked to draw a line 
connecting numbers from 1 to 25 consecutively (Arbuthnott & Frank, 2000). Likewise, the 
TMT-B also involves drawing a line, but subjects are asked to connect consecutive numbers 
and letters in an alternative manner (Arbuthnott & Frank, 2000). In the interference trial of 
the Stroop Color-Word Test, subjects are asked to name the color of the ink in which a word 
is printed whilst ignoring the meaning of that word itself (Sisco, Slonena, Okun, Bowers, & 
Price, 2016). Scores on the TMT-A and TMT-B as well as the Stroop Color-Word Test were 
reversed for the statistical analyses, so a higher score indicated better performance. 
Second, the immediate and delayed recall performance on the 15-Word Verbal 
Learning Test (15-WVLT), plus the performance on the Visual Association Test (VAT) 
loaded on memory function (Lezak, Howieson, & Loring, 2004, as discussed in Moonen et 
al., 2017). In the 15-WVLT, subjects are asked to recall as many as possible of fifteen nouns 
read aloud to them, either immediately (immediate recall) or after a 20-minute delay (delayed 
recall) (Bleecker, Bolla-Wilson, Agnew, & Meyers, 1988). In the VAT subjects are first 
presented with six drawings displaying pairs of interacting objects, which they are asked to 
name (Diesfeldt, Prins, & Lauret, 2018). Later, subjects are cued with only one object from 
each pair and are asked to name the corresponding object to complete the matched set. Higher 
scores on the 15-WVLT and the VAT indicated better performance (Diesfeldt et al., 2018).  
Finally, the Letter Digit Substitution Test (LDST) was administered to assess 
psychomotor speed and speed of information processing (Van der Elst, Van Boxtel, Van 
Breukelen, & Jolles, 2008). The LDST key provides the subject with the numbers 1 to 9, each 
paired with a different letter, then asking the subject to replace randomized letters with their 
corresponding number as indicated by the key. Scores indicate the amount of accurate 
substitutions made in 90 seconds, thus higher scores on the LDST indicate better performance 
(Van der Elst et al., 2008).  
As aforementioned, the overall cognition compound score was computed by 
calculating the mean of the standardized scores on these six tests described above (namely the 
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delta of the TMT, the Stroop Color-Word Test, the WVLT immediate recall, the WVLT 
delayed recall, the VAT, and the LDST). Subtracting the overall cognition compound score at 
baseline from the overall cognition compound score at the four year follow up reflects the 
change (∆) in overall cognition. Thus, negative delta scores serve as an indication of 
cognitive decline.  
 
Procedure  
The DANTE study was approved by the Medical Ethical Committee of the Leiden 
University Medical Center, and all participants provided written informed consent (Moonen 
et al., 2017). Firstly, information on medical history and medication use was obtained from 
the participants’ general physician by means of structured questionnaires (Moonen, Foster-
Dingley, et al., 2015). In addition, the general physician conducted the Mini Mental State 
Examination (MMSE) (Folstein, Folstein, & McHugh, 1975) at baseline and follow up. 
Although the MMSE score was not included to compute the overall cognition compound 
score as described above, participants who scored less than 21 points were excluded from the 
DANTE study (Moonen, Foster-Dingley, et al., 2015). All other measures were conducted by 
trained DANTE researchers during home visits at baseline and follow up sessions.  
Detailed procedures of the DANTE study are described elsewhere; here, only the 
aspects that were relevant for the current thesis study are summarized (Foster-Dingley et al., 
2015; Foster-Dingley et al., 2018; Moonen, Bertens, et al., 2015; Moonen, Foster-Dingley, et 
al., 2015; Moonen et al., 2017). Standardized interviews were used at baseline to assess 
demographic characteristics. Moreover, a neuropsychological assessment was conducted 
during the home visits at baseline and four year follow up to measure cognitive and 
psychological functioning. Cognitive functioning was measured by administering the six 
cognitive tests described in the Measures section above, in the following order: the WVLT 
immediate recall, the Stroop Color-Word Test, the TMT-A and TMT-B, the WVLT delayed 
recall, the VAT, and the LDST. Subsequently, psychological functioning was assessed at 
baseline by administering the GDS-12 and the AS. 
 
Statistical analyses  
All analyses were conducted using IBM SPSS version 23. Descriptive statistics were 
used to explore the socio-demographic characteristics (age, gender, educational level) and 
lifestyle characteristics (BMI, current smoking, alcohol consumption) at baseline for all 
participants. In addition, independent samples t-tests, non-parametric Mann-Whitney U tests, 
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and Chi-squared tests were used to examine differences between the included group 
(complete baseline and follow up data) and excluded group (incomplete baseline and follow 
up data). Independent samples t-tests were used to compare means for the normally 
distributed continuous variables, namely age, BMI, the WVLT immediate recall, the WVLT 
delayed recall, the LDST, and the AS. The Mann-Whitney U test was used to compare 
medians for the continuous variables that were not normally distributed. Chi-squared tests 
were used to compare categorical variables between the groups. Paired samples t-tests were 
run to examine whether cognitive test results changed over time for the included group, 
comparing the test scores at baseline to the scores at follow up.  
All three hypotheses were tested using linear regression analyses, meaning three 
regression analyses were run in total. Participants from both the intervention group as well as 
the control group of the DANTE study were taken into account in the analyses irrespective of 
group allocation, as long as they met the inclusion criteria (see Participants section). 
Cognitive decline according to the change (Δ) in overall cognition compound scores between 
baseline and follow up was entered as the dependent variable in all of the analyses. To test 
the first hypothesis, scores on the AS at baseline were entered as the independent variable in 
the first model. Then, two additional models were created to test the effects of covariates by 
comparing the beta coefficients and significance values to the first model. The second model 
was adjusted for the effects of age and gender. The third model was adjusted for all the 
included covariates, namely age, gender, years of education, current smoking, units of 
alcohol consumption per week, and BMI. These sociodemographic factors have all been 
shown to affect cognition and cognitive decline and should thus be controlled for when 
determining the main predictive effects (Santos, Moreira, Castanho, Sousa, & Costa, 2017). 
The second hypothesis was tested by means of a similar approach, except the scores on the 
GDS-12 at baseline were entered as the independent variable in the first model. To test the 
third hypothesis, the interaction term of apathy and depression at baseline was first computed 
by multiplying the standardized Z-scores of the AS by the standardized Z-scores of the GDS-
12. The interaction term was then added as the independent variable in the first model, 
together with the standardized AS scores as well as the standardized GDS-12 scores. The 
second and third model were the same as those used to test the respective effects of apathy 
and depression. 
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Results 
 
Table 1 presents the baseline characteristics of the total sample (n = 308), as well as 
those of the included (n = 154) and excluded (n = 154) subgroups for the analyses.  
 
Table 1. Baseline characteristics. 
Characteristic  Total 
(n = 308)  
Included  
(n = 154) 
Excluded  
(n = 154) 
P-value  
(t-test or χ2) 
Demographic & clinical      
Age in years, mean (SD) 81.0 (4.3)  80.2 (3.9) 81.7 (4.6) 0.002* 
Male sex, n (%) 128 (41.6%) 58 (18.8%) 70 (22.7%) 0.2 
Years of education, median 
(Q1, Q3)  
9.0 (6.0, 10.0) 9.0 (7.0, 10.3) 8.0 (6.0, 10.0) 0.001* 
BMI, mean (SD)  26.7 (4.1) 26.8 (3.8) 26.7 (4.4) 0.78 
Current smoking, n (%) 27 (8.8%) 11 (3.6%) 16 (5.2%) 0.42 
Alcohol consumption  
>14 units per week, n (%) 
31 (10.1%) 12 (3.9%) 19 (6.2%) 0.26 
MMSE, median (Q1, Q3) 26 (25, 27)  27 (26, 27) 26 (25, 27) <0.001* 
Executive function     
TMT∆ in seconds,  
median (Q1, Q3) 
131.0  
(78.0, 197.0) 
97.0  
(63.5, 165.8) 
161.0  
(103.0, 210.0) 
<0.001* 
Stroop Interference score in 
seconds, median (Q1, Q3) 
31.0  
(21.5, 48.5) 
28.0  
(18.4, 44.4) 
34.0  
(25.5, 57.5) 
0.001* 
Memory function     
WVLT Immediate Recall 
score, mean (SD)  
16.6 (5.7) 18.2 (5.4) 15.1 (5.5) <0.001* 
WVLT Delayed Recall 
score, mean (SD)  
4.5 (2.7) 5.1 (2.8) 3.9 (2.6) <0.001* 
VAT score, median (Q1, Q3) 12 (10, 12) 12 (11, 12) 11 (9, 12) <0.001* 
Psychomotor speed     
LDST score in seconds, 
mean (SD) 
30.8 (9.4) 34.3 (8.5) 27.3 (9.1) <0.001* 
Psychological functioning      
AS score, mean (SD) 11.2 (4.5) 10.6 (4.5) 11.9 (4.5) 0.016* 
GDS-12 score, median  
(Q1, Q3) 
1 (0, 2)  0 (0, 2) 1 (0, 2) 0.28 
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Participants were on average 81 years old at baseline, and 41.6% were men. 
Compared to participants in the excluded group, those in the included group were younger, 
t(306) = 3.172, p = 0.002, completed more years of education, U = 9377.0, p = 0.001, and 
scored lower on the AS at baseline, t(305) = 2.428, p = 0.016. Scores on the GDS-12 did not 
differ between the two groups, U = 10774.5, p = 0.28. Furthermore, the included and 
excluded groups differed on all cognitive measures at baseline. Included participants were 
faster than the excluded participants on the TMT, U = 7743.0, p < 0.001, as well as the 
Stroop Color-Word Test, U = 8431.0, p < 0.001. Subjects that were included in the analyses 
attained higher scores on the WVLT Immediate Recall, t(306) = -4.989, p < 0.001, the 
WVLT Delayed Recall, t(306) = -3.781, p < 0.001, the VAT, U = 8604.5, p < 0.001, the 
LDST, t(304) = -6.961, p < 0.001, and the MMSE, U = 8754.5, p < 0.001, compared to the 
participants that were excluded.  
Paired samples t-tests were run to assess whether cognitive test results changed over 
time for the included group. Results of these paired samples t-tests are displayed in Table 2. 
Scores declined over time on the TMT, t(144) = -6.457, p < 0.001, the VAT, t(152) = -4.298, 
p < 0.001, the LDST, t(152) = -6.637, p < 0.001, the WVLT Immediate Recall, t(153) = -
1.569, p < 0.001, and the WVLT Delayed Recall, t(153) = -4.555, p < 0.001. However, scores 
improved over time on the MMSE, t(153) = 3.921, p < 0.001, and the Stroop Color-Word 
Test, t(146) = 4.489, p < 0.001.  
 
 
 
Table 2.  Changes over time in cognitive test results in 154 participants. 
Test  Baseline  Follow up  Delta  P-value 
N  Mean (SD)  N  Mean (SD)  Mean (SD)  
MMSE 154 26.25 ( 1.05) 154 27.02 (2.63) 0.77 (2.42) < 0.001* 
TMT 154 149.09 (66.08) 145 122.46 (64.31) -31.39 (58.55) <0.001* 
Stroop 154 234.98 (32.41) 147 253.03 (48.91) 16.86 (45.54) <0.001* 
VAT 154 11.31 (1.45) 153 10.53 (2.80) -0.79 (2.28) <0.001* 
LDST 154 34.26 (8.45) 153 31.63 (9.41) -2.67 (4.97) <0.001* 
WVLT 
(immediate) 
154 18.17 (5.37) 154 15.94 (5.02) -2.23 (4.13) <0.001* 
WVLT 
(delayed) 
154 5.05 (2.75) 154 4.21 (2.73) -0.84 (2.28) <0.001* 
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 A linear regression analysis testing three models was used to examine the first 
hypothesis that a higher score on the AS at baseline was related to more cognitive decline at 
follow up. The assumptions for normality, multicollinearity, and homoscedasticity were 
checked and were not violated. Results of the linear regression analysis are displayed in 
Table 3. According to the first model of the linear regression analysis there was no significant 
relationship between the total baseline AS scores as independent variable (M = 10.62), and 
the dependent variable of cognitive decline, R2 < 0.001, F(1,151) = 0.016, p = 0.901. The 
results persisted after adjusting for age and gender in the second model, R2 = 0.028, F(3,149) 
= 1.452, p = 0.230. Furthermore, the results remained robust after adjusting for all included 
covariates in the third model, R2 = 0.050, F(7,145) = 1.100, p = 0.366. The GDS-12 score was 
excluded as a covariate in the third model due to the correlation between the AS and GDS-12, 
r = 0.358, p < 0.001, displayed in Figure 1. Thus, apathy was not found to be a significant 
predictor of cognitive decline in the first (β = -0.010, p = 0.901), second (β = -0.009, p = 
0.909), or third model (β = -0.016, p = 0.845). 
To test the second hypothesis that the score on the GDS-12 at baseline did not have a 
predictive effect on cognitive decline another linear regression analysis was performed, 
testing three models. Again, the assumptions were checked and not violated. Results of the  
 
Table 3.  Results of the regression analyses on the relationship between apathy, depression, and 
cognitive decline.  
 β SE P-value 
Apathy    
 Model 1 -0.010 0.008 0.901 
Model 2* -0.009 0.008 0.230 
Model 3** -0.016 0.008 0.366 
Depression    
Model 1 0.074 0.021 0.365 
Model 2* 0.078 0.022 0.158 
Model 3** 0.083 0.022 0.283 
Apathy x depression    
Model 1 -0.057 0.037 0.696 
Model 2* -0.021 0.038 0.358 
Model 3** -0.005 0.038 0.442 
*Model 2 is adjusted for age and gender.  
**Model 3 is adjusted for age, gender, years of education, current smoking, alcohol consumption, and BMI.   
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Figure 1. Scatterplot displaying the relationship between the total AS score at baseline and the total 
GDS-12 score at baseline. 
 
linear regression analysis are displayed in Table 3. No significant relationship between the 
total GDS-12 score as the independent variable and cognitive decline as the dependent 
variable was found in the first model, R2 = 0.005, F(1,151) = 0.825, p = 0.365. The results 
remained robust when adjusting for age and gender in the second model, R2 = 0.034, F(3,149) 
= 1.756, p = 0.158. Furthermore, the results remained robust when adjusting for all included 
covariates in the third model, R2 = 0.057, F(7,145) = 1.242, p = 0.283. Thus, according to the 
results of the linear regression analysis, depression was not found to be a significant predictor 
of cognitive decline in the first (β = 0.074, p = 0.365), second (β = 0.078, p = 0.345), or third 
model (β = 0.083, p = 0.323). 
Lastly, a third linear regression analysis was conducted to test the hypothesis that the 
interaction term between the AS and GDS-12 scores did not have a predictive effect on 
cognitive decline. Again, the linear regression analysis consisted of three statistical models. 
The assumptions were checked and not violated. Results of the linear regression analysis are 
displayed in Table 3. No significant association was found between the interaction term of 
AS and GDS-12 scores as the independent variable and cognitive decline as the dependent 
variable in the first model, R2 = 0.010, F(3,149) = 0.481, p = 0.696. Adjusting for age and 
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gender in the second model did not reveal a significant relationship either, R2 = 0.036, 
F(5,147) = 1.110, p = 0.358. Moreover, results remained robust when controlling for all the 
included covariates in the third model, R2 = 0.059, F(9,143) = 1.001, p = 0.442. Thus, results 
of the linear regression analysis did not indicate the interactive effect between total AS and 
GDS-12 scores to be a significant predictor of cognitive decline in the first (β = -0.061, p = 
0.555), second (β = -0.023, p = 0.828), or third model (β = -0.005, p = 0.964). 
 
Post hoc analyses  
 The effect of years of education on cognitive decline was explored post hoc to assess 
whether this covariate was masking the emergence of the main effects. This post hoc analysis 
was conducted by splitting the included participants into two groups based on the median of 
years of education (Mdn = 9.0). Participants with nine or more years of education were 
considered highly educated, whereas those with less than nine years of education were 
considered lowly educated. Independent samples t-tests were conducted to examine the 
differences in delta scores per cognitive test between the two groups, as displayed in Table 4. 
Delta scores did not differ between the low educated and the high educated on the MMSE, 
t(152) = -1.423, p = 0.157, the TMT, t(143) = -0.234, p = 0.815, the Stroop Color-Word Test, 
t(145) = -0.055, p = 0.956, the VAT, t(151) = -0.733, p = 0.464, the WVLT Immediate 
Recall, t(152) = 1.572, p = 0.118, and the WVLT Delayed Recall, t(152) = 1.482, p = 0.140. 
As displayed in Figure 2, the high educated group showed a steeper decline over time on the 
LDST than those who were low educated, t(151) = 2.003, p = 0.047. 
 
Table 4.  The effect of years of education on cognitive decline in 154 participants. 
Testa Low educatedb High educatedc P-value 
N  Mean (SD)  N  Mean (SD)   
∆MMSE 64 0.44 (2.17) 90 1.0 (2.57) 0.157 
∆TMT 58 -32.79 (65.78) 87 -30.46 (53.57) 0.815 
∆Stroop  61 16.61 (35.98) 86 17.03 (51.46) 0.956 
∆VAT 63 -0.95 (2.50) 90 -0.68 (2.11) 0.464 
∆LDST 63 -1.71 (4.35) 90 -3.33 (5.28) 0.047* 
∆WVLT (immediate) 64 -1.61 (3.73) 90 -2.67 (4.36) 0.118 
∆WVLT (delayed) 64 -0.52 (2.21) 90 -1.07 (2.32) 0.140 
a
Difference in test scores: Baseline subtracted from follow up. Negative values indicate decline. 
b
Low educated is defined as less than 9 years of education.  
c
High educated is defined as 9 or more years of education. 
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Figure 2. Scatterplot displaying the relationship between years of education and the delta LDST 
score. 
 
Discussion 
 
The aim of this master thesis study was to explore the predictive effect of apathy and 
depression, both respectively and interactively, on cognitive decline in a sample of older 
patients with hypertension. Considering the current aging trend, understanding factors 
contributing to cognitive dysfunction could provide insight in preventing or delaying age-
related cognitive disorders (Vloeberghs et al., 2018; Walker et al., 2017). Based on previous 
research in the fields of MCI and dementia, apathy was expected to have a predictive effect 
on cognitive decline. Due to inconsistent findings in previous studies, depression was not 
expected to have a predictive effect on cognitive decline. Lastly, based on previous research 
indicating that apathy and depression should be considered separate constructs and are 
inconsistently associated with cognition when studied interactively, the interaction between 
apathy and depression was not expected to have a predictive effect on cognitive decline. 
Results of the current study indicated that although scores on almost all individual cognitive 
tests declined over time, neither apathy nor depression significantly predicted cognitive 
decline in older patients with hypertension. Moreover, the interactive effect between apathy 
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and depression was not found to be a predictor of cognitive decline in this study sample. 
Thus, it was for example not the case that the effect of apathy was strengthened if the patient 
was also suffering from depression, nor the other way around. Absence of the main predictive 
effects remained robust after adjustment for age and gender and for all included covariates. 
For example, no significant relationship was found post hoc between years of education and 
cognitive test scores, except for psychomotor speed and speed of information processing. 
The findings are not in line with the first hypothesis, nor with previous studies that did 
find a relationship between apathy and subsequent cognitive decline in age-related cognitive 
disorders such as AD, PD, MCI, and CSVD (Fitts et al., 2015; Foster-Dingley et al., 2015; 
Hollocks et al., 2015; Kirsch-Darrow et al., 2011; Palmer et al., 2010; Richard et al., 2012).  
However, it should be noted that previous research using data from the DANTE study did not 
find a relationship between apathy and cognition either (Moonen, Foster-Dingley et al., 
2015). Furthermore, the findings are conform the second hypothesis and previous research in 
the field of cognitive decline and depression in the age-related cognitive disorders mentioned 
above (Richard et al., 2012; Steenland et al., 2012; Vloeberghs et al., 2018). Moreover, the 
findings are conform the third hypothesis and in line with previous studies reporting 
inconsistent interactive effects of apathy and depression on cognition (Baudic et al., 2006; 
Meyer et al., 2014; Nakaaki et al., 2008; Zhu et al., 2019). Research by Hollocks et al. (2015) 
concerning CSVD patients offers a possible explanation for the confirmation of our second 
and third hypothesis. As described in the introduction, the increased prevalence of apathy and 
depression in CSVD patients may be caused by white matter damage to cortico-subcortical 
pathways important for emotion regulation (Hollocks et al., 2015). Diffusion Tensor Imaging 
(DTI) revealed that white matter microstructural changes are indeed associated with apathy, 
but not depression. Cerebrovascular disease thus affects numerous brain structures and their 
connections, leading to cognitive deficits and apathy. Depression however, although common 
in CSVD patients, “may to some extent be secondary to motivational loss and cognitive 
impairment” rather than a more direct result of cerebrovascular disease (Hollocks et al., 2015, 
p. 3812).  
Findings of the current study imply that elderly hypertension patients without serious 
cognitive impairment do not have a greater risk of more rapid cognitive decline depending on 
their levels of apathy and depression. In clinical practice, the results of the current study 
imply that apathy and depression in elderly hypertension patients can be dissociable, allowing 
for the development of distinct treatment approaches (Hollocks et al., 2015). However, based 
on our findings it cannot be stated that the treatment of apathy or depression will help to limit 
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further cognitive decline in elderly hypertension patients. Nonetheless, in the current study 
sample those with higher levels of apathy at baseline also performed worse on all cognitive 
tests, possibly indicating that there may be a shared underlying etiology which is interesting 
to explore further. Considering the lack of predictive effect of apathy found in this study 
despite considerable empirical background with contrasting findings, further research into the 
relationship between apathy and cognitive decline is warranted should the limitations of the 
current study listed below be taken into careful consideration.  
Several factors may explain the contradictory findings concerning the lack of effect of 
apathy on cognitive decline in the current study compared to previous research. Firstly, it 
may be the case that there really is no relationship between apathy and cognitive decline in 
elderly patients suffering from hypertension. Secondly, participants that were excluded from 
the analyses showed higher levels of apathy at baseline, thus the most apathetic participants 
were not taken into consideration in this study. This could imply an underestimation of the 
true effect size, an implication also argued in aforementioned research (Starkstein et al., 
2006). Thirdly, the study samples used in previous research may not be comparable to the 
current study sample. As discussed in the introduction, prior studies often involved patients 
with clinical conditions such as MCI, PD, AD, or CSVD, rather than hypertension (Fitts et 
al., 2015; Hollocks et al., 2015; Kirsch-Darrow et al., 2011; Palmer et al., 2010; Richard et 
al., 2012). These clinical conditions are known to be clearly related to cognitive problems, 
whereas hypertension may be considered more of a risk factor rather than an indicator for 
cognitive dysfunction. Perhaps the relationship between apathy and cognitive decline is 
strongest in populations already experiencing a serious cognitive or cerebrovascular disorder. 
Lastly, the contrasting findings of the current study in comparison to previous research may 
be due to differences in measures. For instance, the study by Fitts et al. (2015) used caregiver 
reports to measure apathy in PD patients, rather than a self-report questionnaire such as the 
AS used in the current study. McKinlay et al. (2008) argued that the level of agreement 
between caregiver reports and the AS is low, thus studies using different measures should be 
compared with caution. However, McKinlay et al. (2008) found that the AS may register 
higher levels of apathy than caregiver reports, and other studies using the AS did manage to 
find a predictive effect, thus our choice of measure was considered to be appropriate. 
Notable strengths of the current study include the following. Data was retrieved from 
the DANTE study, a longitudinal study using standardized measures (Moonen et al., 2015). 
The number of participants included at baseline was substantial in the DANTE study, and the 
dropout rate at baseline was low. Moreover, cognition was measured extensively in the 
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DANTE study, making use of seven different and well-validated tests (Moonen et al., 2015). 
Thus, multiple cognitive domains were taken into consideration to provide a comprehensive 
overview of overall cognition, whereas previous studies have often only focused on one 
specific cognitive domain (Moonen et al., 2015; Nakaaki et al., 2008; Sisco et al., 2016). 
Lastly, the current study has accounted for numerous confounders, aiming for a clearer 
determination of the main effects.  
However, some limitations should also be considered. First and foremost, there was 
substantial attrition. As mentioned previously, half (n = 154) of the total (n = 308) number of 
participants were excluded from the data analyses, mostly due to one or more cognitive test 
scores reported missing at follow up. This may have introduced selection bias in our study 
(Lewin, Brondeel, Benmarhnia, Thomas, & Chaix, 2018). As discussed in the results section, 
the group excluded from the analyses due to missing data performed significantly worse on 
all cognitive tests at baseline in comparison to the included group. Therefore, it could be 
argued that the results of the current study are fitting for those who age relatively well, but 
are not generalizable to those who experience substantial cognitive deterioration within the 
span of a couple of years. Moreover, we used delta scores as a measure of cognitive decline 
and did not apply multiple imputation techniques. Missing data pose a limitation for the 
calculation of delta scores, as scores can only be computed for complete cases. However, 
complete cases cannot be considered representative of the total sample (Lewin et al., 2018). 
Instead of using delta scores, cognitive decline could for instance be defined by using a 
multilevel linear regression analysis, accounting for missing data by means of a repeated 
measurement design (Akoudad et al., 2016). Furthermore, statistical approaches such as 
Bayesian tests may provide a more detailed understanding of the direction of insignificant 
effects. Bayesian tests compare the average predictive adequacy of the alternative hypothesis 
against that of the null hypothesis (Wagenmakers, Morey, & Lee, 2016). Thus unlike 
traditional hypothesis tests, Bayesian methods quantify the ability of each hypothesis to 
predict observed data, instead of rejecting the null hypothesis based on a probability level 
(Wagenmakers et al., 2016). As such, Bayesian tests may offer more insight into the 
relationship between apathy and cognition, whereas traditional regression analyses do not 
permit such exploration since effects did not reach significance. 
Future research should foremost try to prevent attrition, or otherwise take the large 
proportion of missing data into consideration. In addition to the suggestions provided above, 
studies could consider collecting data at multiple time points rather than at a single follow up. 
This would make it possible to study cognitive decline over time in a more detailed manner 
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rather than by using a delta score. For instance, a Cox proportional hazard analysis could be 
applied instead of a linear regression analysis. This could provide us with more information 
concerning the rate of decline as well as the factors affecting decline, and also takes into 
account missing data which may be censored. This may help to identify not only predictors of 
cognitive decline, but also protective factors by studying the patients showing slower rates of 
decline. 
In conclusion, the findings of the current study suggest that apathy and depression 
cannot be considered to have a predictive effect on cognitive decline in a population of 
elderly hypertension patients, both respectively nor interactively. The main effects remained 
absent after adjustment for potential confounding variables. Although the absence of the 
effects of depression and the interactive term was expected, the lack of effect of apathy on 
cognitive decline is not in line with previous research. However, the high dropout rate and 
thus the large proportion of missing data at follow up may be an important contributor to 
these findings, as indications for selective attrition make the existence of biases plausible. 
Future research should attempt to prevent attrition as much as possible, and handle missing 
data differently should the dropout indeed be due to compromised cognition. In this way 
those with more seriously impaired cognition can be studied in more detail before it is 
concluded that the effects of apathy on cognitive decline are truly absent in elderly 
hypertension patients.  
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Figure A1. Flowchart of the DANTE study. 
 
356 participants with baseline data 
(DANTE1) approached for 4YFU 
(DANTE2) 
48 missing  
30 refused 
11 died 
 7 moved address  
 
308 participants with baseline data 
included for 4YFU 
5 missing: baseline AS 
or GDS-12 
1 total AS score  
4 total GDS-12 score   
 
303 participants with complete 
psychological baseline data (AS & 
GDS-12) who also joined 4YFU 
149 missing: more than 
1 cognitive test at 
baseline or 4YFU 
8 missing 2 tests  
5 missing 3 tests 
4 missing 4 tests  
4 missing 5 tests  
3 missing 6 tests  
118 missing 7 tests  
6 missing 8 tests  
1 missing 9 tests 
 
 
 154 participants with complete 
AS & GDS-12 baseline data who 
miss no more than one cognitive 
test at baseline or 4YFU  
